{"id":336,"date":"2016-05-04T17:33:13","date_gmt":"2016-05-04T15:33:13","guid":{"rendered":"https:\/\/www.optimhal-protecsom.com\/en\/qui-sommes-nous\/"},"modified":"2022-02-14T12:49:52","modified_gmt":"2022-02-14T11:49:52","slug":"about-us","status":"publish","type":"page","link":"https:\/\/www.optimhal-protecsom.com\/en\/about-us\/","title":{"rendered":"About us"},"content":{"rendered":"
<\/p><\/div><\/div><\/div>\n Laboratoire OptimHal-ProtecSom\u00a0<\/strong>is a Norman research SME (Small and Medium-sized Businesses) which designs and manufactures in France medical devices for the lung deposition of medicine, asthma and allergy.<\/p> The company, which dedicates a third of its resources directly to research, expands in part through an assertive politic of partnership :\u00a0<\/p> Joint project from our multidisciplinary research team and those partners lead to several innovations and numerous patents, some co-owned with public research bodies such as INSERM or university laboratories in particular the University of Normandy or the Fran\u00e7ois Rabelais university of Tours.<\/p> All devices presently marketed by\u00a0ProtecSom-OptimHal<\/strong>\u00a0benefited from these research efforts, were developed in France with\u00a0ISO 13485:2016-certified<\/strong>\u00a0processes and are manufactured under the same quality\u00a0management system certifications<\/strong>.<\/p> In France,\u00a0OptimHal-ProtecSom\u00a0adheres to the national agreement with the French social security system n\u00b0 50 2 60068 7<\/em><\/p>\n <\/p><\/div><\/div>\n<\/p><\/a><\/p>
<\/div><\/div> Our implantations<\/strong><\/a><\/h4>\n
<\/p>\n<\/div><\/div>
History<\/span><\/strong><\/a><\/h4>\n
<\/a><\/p>\n
<\/a>The Laboratory<\/span><\/strong><\/h4>\n
\n